ImmunoGen (IMGN) Earnings Date, Estimates & Call Transcripts → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free imgn Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainability Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueIMGN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IMGN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceDoes this chart look familiar?Investors who understand when to get in — and when to get out… Can make a lot of money. Like in the chart, I showed you above…Get all the information here. ImmunoGen Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243($0.11)$0.07$0.00 Q2 20243($0.10)$0.07$0.01 Q3 20243($0.09)$0.08$0.02 Q4 20243$0.04$0.14$0.09 FY 202412($0.26)$0.36$0.12 Q1 20251$0.10$0.10$0.10 Q2 20251$0.10$0.10$0.10 Q3 20251$0.11$0.11$0.11 Q4 20251$0.23$0.23$0.23 FY 20254$0.54$0.54 $0.54 Get ImmunoGen Earnings AlertsEnter your email address below to receive the latest news and earnings results for IMGN and its competitors with MarketBeat's FREE daily newsletter. ImmunoGen Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript11/2/2023Q3 2023$0.02$0.10+$0.08$0.10$106.98 million$113.43 million7/31/2023Q2 2023($0.16)($0.02)+$0.14($0.02)$49.15 million$83.20 million 4/28/2023Q1 2023($0.25)($0.16)+$0.09($0.16)$21.63 million$49.90 million 3/1/2023Q4 2022($0.29)($0.23)+$0.06($0.23)$17.18 million$41.17 million 11/4/2022Q3 2022($0.26)($0.31)($0.05)($0.31)$11.81 million$15.38 million7/29/2022Q2 2022($0.22)($0.24)($0.02)($0.24)$16.18 million$14.20 million Get the Latest News and Ratings for IMGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImmunoGen and its competitors with MarketBeat's FREE daily newsletter. 5/6/2022Q1 2022($0.21)($0.10)+$0.11($0.10)$20.84 million$38.10 million 2/25/2022Q4 2021($0.18)($0.17)+$0.01($0.17)$25.93 million$28.00 million 10/29/2021Q3 2021($0.19)($0.18)+$0.01($0.18)$19.03 million$9.20 million 7/30/2021Q2 2021($0.18)($0.15)+$0.03($0.15)$18.92 million$16.90 million ImmunoGen Earnings - Frequently Asked Questions How much revenue does ImmunoGen generate each year? ImmunoGen (NASDAQ:IMGN) has a recorded annual revenue of $287.61 million. How much profit does ImmunoGen generate each year? ImmunoGen (NASDAQ:IMGN) has a recorded net income of -$222.93 million. IMGN has generated -$0.31 earnings per share over the last four quarters. What is ImmunoGen's EPS forecast for next year? ImmunoGen's earnings are expected to grow from $0.08 per share to $0.37 per share in the next year, which is a 362.50% increase. More Earnings Resources from MarketBeat Related Companies: Legend Biotech Earnings Penumbra Earnings Bio-Rad Laboratories Earnings Bio-Rad Laboratories Earnings Encompass Health Earnings Ascendis Pharma A/S Earnings Viking Therapeutics Earnings Chemed Earnings Cerevel Therapeutics Earnings BellRing Brands Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:IMGN) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersElon’s New Device is About to Shock the WorldInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsNo experience to confident trader, meet my student…Wealth Builders InstituteCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOIC Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.